MedDataX Logo

Meditation and Hypnosis for Chronic Depressed Mood

NCT ID: NCT00226863

Last Updated: 2005-09-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study examined whether meditation or group psychotherapy including hypnosis plus education, compared to an educational control, would ameliorate long-term depressed mood.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Long Term Depressed Mood

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

meditation plus education

Intervention Type BEHAVIORAL

group psychotherapy with hypnosis plus education

Intervention Type BEHAVIORAL

education

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Currently meeting DSM-IV criteria for a chronic depressive disorder, with the requirement that depressive symptoms had to have lasted for at least 2 years without a remission of 2 months or more.
* Being 18 years of age or older.
* Being sufficiently proficient in English to be able to participate in group therapy.
* Being able to attend weekly meetings at Stanford.

Exclusion Criteria

* Concurrent bipolar disorder or severe depressive disorder (this latter was determined in supervision for the SCID interviews).
* Presence or history of psychosis.
* A current primary diagnosis of panic disorder, generalized anxiety disorder, or PTSD.
* A current primary diagnosis of drug or alcohol dependency or abuse (within the last 3 months).
* Serious suicidal risk, as defined by:
* Current suicidality, i.e., beyond simple ideation (e.g., making threats or attempts; gathering means; has a plan); OR
* Serious prior attempts (bodily harm; gathered means; hospitalization).
* Has a significant medical condition that could interfere with participation in meditation/yoga.
* Current participation in psychotherapy or a meditation group.
* Has started (or changed level or type of) prescribed antidepressant medication or St. John's Wort in the previous 3 months.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stanford University

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lisa D. Butler, Ph.D.

Role: STUDY_DIRECTOR

Stanford University

David Spiegel, M.D.

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1HSA698

Identifier Type: -

Identifier Source: org_study_id